Back to search

United Kingdom· GB-APID-39089111000001100

Femoston-conti 0.5mg/2.5mg tablets

A medicinal product containing estradiol + dydrogesterone, registered in United Kingdom by Pilsco Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedFemoston-conti 0.5mg/2.5mg tabletsATC—REGISTER NO.GB-APID-3908911100000…PACKS LISTED1CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Estradiol + Dydrogesterone
Manufacturer
Pilsco Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    05060669873068

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Estradiol + dydrogesterone in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All estradiol + dydrogesterone products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Femoston, Femoston Conti
  • Belgium · Femoston, Femoston 2/10
  • Cyprus · Femoston
  • Czechia · Femoston, Femoston Conti
  • Germany · Femoston, Femoston Conti
  • Denmark · Femoston, Femoston Conti
  • Estonia · Femoston, Femoston Conti
  • Spain · Femfascon, Femoston
  • Finland · Femoston, Femoston Conti
  • France · Climaston
  • Greece · Femaston
  • Croatia · Femoston, Femoston Conti
  • Ireland · Femoston, Femoston-Conti
  • Italy · Femoston, Femoston Conti
  • Lithuania · Femoston, Femoston Conti
  • Luxembourg · Femoston, Femoston Conti
  • Latvia · Femoston, Femoston Conti
  • Malta · Femoston, Femoston-Conti
  • Netherlands · Femoston, Femoston Continu
  • Norway · Femoston, Femostonconti
  • Poland · Femoston, Femoston Conti
  • Portugal · Femoston
  • Sweden · Femoston, Femostonconti
  • Slovenia · Femphascon Conti
  • Slovakia · Femoston, Femoston Conti

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e907a3b8-dc46-485f-83f5-7aa649e85d01
GET /v1/drugs/e907a3b8-dc46-485f-83f5-7aa649e85d01?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "39089111000001100",
  "desc": "Femoston-conti 0.5mg/2.5mg tablets (Pilsco Ltd)",
  "form": "Oral tablet",
  "vpid": "21366211000001107",
  "source": "dmd",
  "vtm_id": "775721007",
  "strength": "2.5 mg",
  "substance": "Estradiol + Dydrogesterone",
  "ingredient": "Dydrogesterone",
  "supplier_code": "37621811000001104"
}

See everything about estradiol + dydrogesterone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.